Molecular Targeting in Oncology
The DOI matches its Crossref record; 7 of the 9 references it cites were found in a registry or an index.
Abstract
In Molecular Targeting in Oncology, authors present an overview of the development of targeted therapies for the treatment of cancer with an emphasis on clinical application. The volume covers the com
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An alternative strategy focuses on identifying a biologically effective dose based on an array of efficacy markers, such as target engagement, pharmacodynamic markers, and, for bispecific therapeutics, trimer formation. 7 , 11 , 12”
From Semimechanistic Physiologically‐Based Pharmacokinetic/Pharmacodynamic Model Informing Epcoritamab Dose Selection for Patients With B‐Cell Lymphomas (2022) · cites this paper as [12]
Citations
Cites
Memorial Sloan-kettering Cancer Center
Colditz, G. A. (2007) · Sage eBooks · doi:10.4135/9781412953979.n401 · Cited by 96
Division of Cancer Treatment and Diagnosis
National Cancer Institute (2020) · Definitions · doi:10.32388/8aqgge · Cited by 14
Champaneria, M. C., Modlin, I. M., Latich, I., Bornschein, J., Drozdov, I. A., & Kidd, M. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-337-0_25 · Cited by 3
National Cancer Institute (2020) · Definitions · doi:10.32388/68bphp · Cited by 2
Cytokine-Based Therapy for Cancer
Koon, H. B., & Atkins, M. B. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-337-0_20 · Cited by 1
Molecularly Targeted Therapy in Pancreatic Cancer
Goel, A., & Kozuch, P. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-337-0_9 · Cited by 1
Targeted Therapies for Prostate Cancer
del Alba, A. G., León‐Mateos, L., Suárez, C., & Méndez, M. J. (2015) · Current clinical pathology · doi:10.1007/978-1-4939-2047-1_17 · Cited by 1
Cited by
Clinical applications of Gallium-68
Banerjee, S. R., & Pomper, M. G. (2013) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2013.01.039 · Cited by 243
EGF Receptor-Targeted Nanocarriers for Enhanced Cancer Treatment
Master, А. M., & Gupta, A. S. (2012) · Nanomedicine · doi:10.2217/nnm.12.160 · Cited by 161
The potential of seaweed as a source of drugs for use in cancer chemotherapy
Murphy, C., Hotchkiss, S., Worthington, J., & McKEOWN, S. R. (2014) · Journal of Applied Phycology · doi:10.1007/s10811-014-0245-2 · Cited by 101
“In addition, considerable efforts are being made to identify molecular targets specific to tumour cells (Kaufman et al. 2008).”
BackgroundDeeney, J. T., Belkina, A. C., Shirihai, O. S., Corkey, B. E., & Denis, G. V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151329 · Cited by 92
Epigenetic memory in development and disease: Unraveling the mechanism
Thiagalingam, S. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188349 · Cited by 68
Metadata
- Authors
- Kaufman, H. L., Wadler, S., & Antman, K. H.
- Affiliations
- Columbia University (US)
- Cornell University (US)
- Boston University (US)
- ORCID
- Howard L. Kaufman
- Venue
- Cancer Drug Discovery and Development
- Publisher
- Humana Press
- Published
- 2008
- OpenAlex
- W651516791
- Semantic Scholar
- 26559762a971134c95ac0cc3ed67fe3d8ae0bd54
- Cited by
- 20
- References
- 9
- Citations by year
- 2023: 1 · 2022: 3 · 2021: 2 · 2020: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 2
- FWCI
- 0.62
- Type
- book
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Humana Press eBooks (publishedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Keywords
- molecular targeting, targeted cancer therapy, anticancer agents, molecularly targeted agents, cancer therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular Targeting in Oncology. https://app.cochat.ai/papers/10.1007/978-1-59745-337-0
- The paper
- Kaufman, H. L., Wadler, S., & Antman, K. H. (2008). Molecular Targeting in Oncology. Cancer Drug Discovery and Development. https://doi.org/10.1007/978-1-59745-337-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.